Support bill on triple talaq and nikah halala, Prasad tells Rahul
New Delhi, July 17: A day after Congress President Rahul Gandhi sought the Prime Minister's support for the passage of the Women's Reservation Bill, Union Law Minister Ravi Shankar Prasad on Tuesday asked him to support the proposed law to prohibit triple talaq and nikah halala.
He said that as national parties, the Bharatiya Janata Party and the Congress cannot have two sets of standards in dealing with women and their rights.
In a letter to Gandhi, which was released to the media, Prasad said: "As part of the new deal, we should approve, in both houses of Parliament, the Women's Reservation Bill, the law prohibiting triple talaq and imposing penal consequence on those who violate the law, and prohibiting nikah halala."
Under the triple talaq practice, a Muslim man can instantly divorce his wife by orally repeating the 'talaq' word thrice. As per 'nikah halala', a woman divorcee has to marry someone else, consummate this marriage to get a divorce and remarry her earlier husband.
Prasad's letter came a day after Gandhi wrote to Prime Minister Narendra Modi to seek his support for the passage of the Women's Reservation Bill in Parliament's monsoon session starting on July 18, claiming that the BJP appears to have had second thoughts on the proposed law even though it was a key promise in its 2014 manifesto.
"As national parties, we cannot have two sets of standards in dealing with women and their rights. We are already too late in conferring the right of adequate representation, equality in personal laws and doing away with such provisions which compromise women's dignity," Prasad said.
The BJP leader also targeted the Congress chief over the lapsing of the Women's Reservation Bill with the dissolution of the last Lok Sabha.
"The bill was originally proposed by the National Democratic Alliance government headed by Atal Bihari Vajpayee but could not be passed for want of a consensus in Parliament.
"It was reintroduced during the UPA-II government in the Rajya Sabha. Despite disturbances, the BJP and NDA stood in firm support of the bill and got it passed in the Rajya Sabha. For reasons best known to the government of that day, no effort was made to get the bill passed in the Lok Sabha," Prasad said.
The Minister said that the Modi government welcomes Gandhi's initiative to support the bill. "However, the government will like to understand fully the reasons why the bill was not taken up for three years by the UPA government in the Lok Sabha and allowed to lapse?"
Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.
Statewide ban on IV Ringer Lactate usage: Dinesh Gundu Rao
Bengaluru: In response to the deaths of postnatal women at Ballari District Hospital, the Karnataka government has temporarily suspended the use of IV Ringer Lactate solution across the state as a precautionary measure, Health Minister Dinesh Gundu Rao announced on Saturday.
Speaking to the media in Bengaluru, the minister explained that doubts about the quality of the IV solution had arisen, prompting the decision. He clarified that Ringer Lactate, along with glucose solutions, has been routinely used in hospitals for years. However, out of the 192 batches supplied by the Karnataka State Drugs Logistics and Warehousing Society, concerns were raised regarding two specific batches.
"In light of these concerns, we stopped the use of all 192 batches as a precaution. Following this, the supplying company obtained a High Court order for testing, and the Central Drugs Laboratory (CDL) conducted an analysis. The CDL report confirmed the usability of the solution, allowing the state to form a technical committee to review and permit the use of certain batches that met quality standards. Despite this, doubts have surfaced specifically at Ballari District Hospital," the minister stated.
To address these concerns, the batches supplied to Ballari Hospital have been sent for anaerobic testing to determine whether the IV solution contributed to the deaths. The test results are expected within a week, after which a final decision on the use of IV Ringer Lactate will be made.
"Until then, we have issued directives to hospitals statewide to suspend the use of IV Ringer Lactate. Every life is important to us, and precautionary measures are essential when suspicions arise," Gundu Rao emphasised.
